XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
4 Months Ended 5 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 02, 2019
Sep. 30, 2020
Cash Flows from Operating Activities      
Net loss $ (13.9) $ (19.0) $ (18.2)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 20.1 26.6 45.3
Amortization of deferred financing costs 0.7 7.5 1.2
Loss on disposal of fixed assets 0.2 1.0 1.7
Deferred income taxes (1.3) (7.2) (0.9)
Loss on derivative contract 6.4    
Amortization of initial value of hedging instrument     (1.2)
Currency (gain) loss on foreign denominated debt and notes payable (0.8) (2.4) 3.2
Amortization of restricted stock units 1.8   5.9
Changes in operating assets and liabilities:      
(Increase) decrease in receivables, net (0.8) 1.8 (4.9)
(Increase) decrease in income tax receivables, net (5.3) 1.7 (4.5)
(Increase) decrease in inventory 2.7 (1.3) (2.7)
(Increase) decrease in prepaid expenses and other assets (0.5) 2.7 (1.0)
Increase (decrease) in accounts payable (14.1) (2.8) 8.2
Increase (decrease) in accrued liabilities 3.1 7.1 6.5
Change in other assets and liabilities 1.4 1.0 (0.8)
Net cash provided by (used in) operating activities (0.3) 16.7 37.8
Capital expenditures:      
Converter equipment (9.7) (9.9) (21.1)
Other capital expenditures (0.8) (0.6) (3.9)
Total capital expenditures (10.5) (10.5) (25.0)
Cash paid for acquisitions (945.6)    
Cash withdrawn from trust account 308.1    
Patent and trademark expenditures (0.2) (0.3) (0.5)
Net cash used in investing activities (648.2) (10.8) (25.5)
Cash Flows from Financing Activities      
Proceeds from issuance of term loans and credit facility 534.6    
Proceeds from sale of common stock 314.7    
Shares subject to Redemption (158.3)    
Financing costs of debt facilities (12.6)    
Payments on term loans and credit facility   (14.4) (1.2)
Payments of promissory note (4.0)    
Payment of deferred registration costs (11.3)    
Net cash provided by (used in) financing activities 663.1 (14.4) (1.2)
Effect of Exchange Rate Changes on Cash (2.7) 1.2 0.5
Net Increase (Decrease) in Cash and Cash Equivalents 11.9 (7.3) 11.6
Cash and Cash Equivalents, beginning of period 1.7 17.5 19.7
Cash and Cash Equivalents, end of period $ 13.6 $ 10.2 $ 31.3